ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2023 Earnings Call Transcript August 2, 2023

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $0.12.

Operator: Good day, ladies and gentlemen and welcome to ACADIA Pharmaceuticals’ Second Quarter 2023 Financial Results Conference Call. My name is [Jeda] and I’ll be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a...